Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-26T00:22:34.229Z Has data issue: false hasContentIssue false
  • English
  • Français

Screening for Colorectal Cancer: What are the Costs?

Published online by Cambridge University Press:  10 March 2009

David Weller ,
John Moss ,
Janet Hiller ,
David Thomas  and
John Edwards
David Weller
Affiliation:
University of Adelaide
John Moss
Affiliation:
University of Adelaide
Janet Hiller
Affiliation:
University of Adelaide
David Thomas
Affiliation:
Institute of Medical and Veterinary Science, Adelaide
John Edwards
Affiliation:
Institute of Medical and Veterinary Science, Adelaide
Get access Rights & Permissions [Opens in a new window]

Abstract

We examined a screening program for colorectal cancer in South Australia in terms of its overall direct costs to society and costs to participants. The best estimate of the cost per cancer detected was $18,924 (Australian dollars). Potential improvements in health outcome through screening are discussed in light of these costs.

Type
General Essays
Information
International Journal of Technology Assessment in Health Care , Volume 11 , Issue 1 , Winter 1995 , pp. 26 - 39
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Allison, J. E., & Feldman, R.Cost benefits of hemoccult screening for colorectal carcinoma. Digestive Diseases & Sciences, 1985, 30, 860–65.CrossRefGoogle ScholarPubMed
2.Barry, M. J., Mulley, A. G., & Richter, J. M.Effect of workup strategy on the costeffectiveness of fecal occult blood screening for colorectal cancer. Gastroenterotogy, 1987, 93, 301–310.CrossRefGoogle ScholarPubMed
3.Brown, K., & Burrows, C.Cost-effectiveness of alternative workup strategies in screening for colorectal cancer. Paper presented at the Twelfth Annual Conference of the Australian Health Economists’ Group, 09 6–7, 1990.Google Scholar
4.Brown, K., & Burrows, C.A prospective cost-effectiveness study of alternative work-up strategies in colorectal cancer screening. Australian Health Review, 1992, 15, 176–89.Google ScholarPubMed
5.Cairns, J., & Shackley, P.Sometimes sensitive, seldom specific: A review of the economics of screening. Health Economics, 1993, 2, 43–53.CrossRefGoogle ScholarPubMed
6.Campion, M. J., Brown, J. R., McCance, D. J., et al. Psycho-sexual trauma of an abnormal cervical smear. British Journal of Obstetrics and Gynaecology, 1988, 95,175–81.CrossRefGoogle Scholar
7.Donaldson, C.The state of the art of costing health care for economic evaluation. Community Health Studies, 1990, 14, 341–56.CrossRefGoogle ScholarPubMed
8.Eddy, D. M.The economics of cancer prevention and detection: Getting more for less. Cancer, 1981, 47, 1,200–09.Google ScholarPubMed
9.Eddy, D. M., Nugent, W., Eddy, J. F., et al. Screening for colorectal cancer in a high-risk population: Results of a mathematical model. Gastroenterology, 1987, 92, 682–92.CrossRefGoogle Scholar
10.Giles, G. G., Armstrong, B. K., & Smith, L. R. (eds.). Cancer in Australia, 1982. City: Australian Association of Cancer Registries and Australian Institute of Health, 1987.Google Scholar
11.Hardcastle, J. D., Chamberlain, J., Sheffield, J., et al. Randomized controlled trial of faecal occult blood screening for colorectal cancer: Results of the first 107,349 subjects. Lancet, 1989, 1, 1160–64.CrossRefGoogle Scholar
12.Hoff, G.Colorectal polyps: Clinical implications, screening and cancer prevention. Scandinavian Journal of Gastroenterology, 1987, 22, 769–75.CrossRefGoogle ScholarPubMed
13.Kristein, M. M.The economics of screening for colorectal cancer. Social Science and Medicine, 1980, 14C, 275–84.Google Scholar
14.Kronborg, O., Fenger, J., Olsen, J., et al. Repeated screening for colorectal cancer with fecal occult blood test. Scandinavian Journal of Gastroenterology, 1989, 24, 599–606.CrossRefGoogle ScholarPubMed
15.Lieberman, D.Cost-effectiveness of colon cancer screening. American Journal of Gastroenterology, 1991, 86, 1789–94.Google ScholarPubMed
16.Macrae, F. A., Tan, K. G., & Williams, C. B.Towards safer colonoscopy: A report on the complications of 5000 diagnostic or therapeutic colonoscopies. Gut, 1983,24, 376–83.CrossRefGoogle ScholarPubMed
17.Mandel, J. S., Bond, J. H., Bradley, M., et al. Sensitivity, specificity and positive predictivity of the hemoccult test in screening for colorectal cancers: The University of Minnesota’s colon cancer control study. Gastroenterology, 1989, 97, 597–600.CrossRefGoogle ScholarPubMed
18.Mandel, J. S., Bond, J. H., Church, T. R., et al. Reducing mortality by screening for fecal occult blood. New England Journal of Medicine, 1993, 328, 1365–71.CrossRefGoogle ScholarPubMed
19.Mant, D., Fitzpatrick, R., Hogg, A., et al. Experiences of patients with false positive results from colorectal cancer screening. British Journal of General Practice, 1990, 40, 423–25.Google ScholarPubMed
20.Marteau, T.Psychological costs of screening. British Medical Journal, 1989, 299, 527.CrossRefGoogle ScholarPubMed
21.Neuhauser, D., Lewicki, A. M.What do we gain from the sixth stool guaic? New England Journal of Medicine, 1975, 293, 255–58.CrossRefGoogle Scholar
22.Thomas, D. W. Colon cancer detection based on the radial immunodiffusion test “Detectacol.” In Young, G. P. & Saito, H. (eds), Fecal occult blood tests: Current issues and new tests. Proceedings of a satellite meeting of the World Congress of Gastroenterology, Sydney, Australia, August 1990. San Diego, CA: SmithKline Diagnostics, 1992.Google Scholar
23.Tuck, J., Walker, A., Whynes, D. K., et al. Screening and the costs of treating colorectal cancer: Some preliminary results. Public Health, 1989, 103, 413–19.CrossRefGoogle ScholarPubMed
24.U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute. Cancer Statistics Review, 1973–1986. NIH publication no. 89–2789. Bethesda, MD: U.S. Department of Health and Human Services, 1989.Google Scholar
25.Wagner, J. L., Herdman, R. C., & Wadhwa, B. A.Cost effectiveness of colorectal cancer screening in the elderly. Annals of Internal Medicine, 1991, 115, 807–17.CrossRefGoogle ScholarPubMed
26.Walker, A., & Whynes, D. K.Participation and screening programmes for colorectal cancer: More would be better? Journal of Health Economics, 1991, 10, 207–25.CrossRefGoogle ScholarPubMed
27.Walker, A., Whynes, D. K., Chamberlain, J. O., & Hardcastle, J. D.The cost of screening for colorectal cancer. Journal of Epidemiology and Community Health, 1991,45,220–24.CrossRefGoogle ScholarPubMed
28.Walker, A. R., Whynes, D. K., & Hardcastle, J. D.Rehydration of guaiac-based fecal occult blood tests in mass screening for colorectal cancer. Scandinavian Journal of Gastroenterology, 1991, 26, 215–18.CrossRefGoogle ScholarPubMed
29.Weller, D. P., Thomas, D. W., Hiller, J. E., et al. Screening for colorectal cancer using an immunochemical test for fecal occult blood: Results of the first two years of a South Australian programme. Australian and New Zealand Journal ofSurgery, 1994, 64, 464–69.CrossRefGoogle Scholar
30.Whynes, D. K., Walker, A. R., & Hardcastle, J. D.Cost savings in mass population screening for colorectal cancer resulting from the early detection and excision of adenomas. Health Economics, 1992, 1, 53–60.CrossRefGoogle ScholarPubMed
31.Woodward, A. J., & Weller, D. P.Colorectal cancer: Implications of mass screening for public health. Medical Journal of Australia, 1990, 153, 81–88.CrossRefGoogle ScholarPubMed